[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.22.2″ _module_preset=”default” background_image=”https:\/\/transitioncf.com\/wp-content\/uploads\/2024\/01\/PCMTCTS2-1400x700_c.jpg” custom_padding=”265px||265px||true|false” custom_padding_tablet=”265px||265px||true|false” custom_padding_phone=”160px||160px||true|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” header_text_color=”#F2F2EB” header_font_size=”45px” header_line_height=”0.8em” header_3_font=”|300|||||||” header_3_text_color=”#F2F2EB” header_3_font_size=”25px” text_orientation=”center” background_layout=”dark” header_font_size_tablet=”45px” header_font_size_phone=”29px” header_font_size_last_edited=”on|phone” header_line_height_tablet=”1em” header_line_height_phone=”1em” header_line_height_last_edited=”on|phone” header_3_font_size_tablet=”25px” header_3_font_size_phone=”20px” header_3_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ use_custom_gutter=”on” gutter_width=”1″ disabled_on=”on|on|off” _builder_version=”4.22.1″ _module_preset=”default” module_alignment=”center” custom_margin=”-27px||-27px||true|false” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.22.1″ _module_preset=”default” custom_padding=”12px||12px||true|false” border_width_right=”1px” border_color_right=”#F2F2EB” global_colors_info=”{}”][et_pb_text disabled_on=”off|off|off” _builder_version=”4.21.0″ _module_preset=”default” text_text_color=”RGBA(255,255,255,0)” global_colors_info=”{}”].
\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text content_tablet=”<\/p>\n
” content_phone=”<\/p>\n
” content_last_edited=”on|phone” _builder_version=”4.22.2″ _module_preset=”default” header_text_color=”#F2F2EB” header_font_size=”45px” header_line_height=”0.8em” header_3_font=”|300|||||||” header_3_text_color=”#F2F2EB” header_3_font_size=”25px” header_3_letter_spacing=”-0.5px” text_orientation=”center” background_layout=”dark” header_line_height_tablet=”1em” header_line_height_phone=”1em” header_line_height_last_edited=”on|phone” header_3_font_size_tablet=”25px” header_3_font_size_phone=”20px” header_3_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|phone” _builder_version=”4.22.2″ _module_preset=”default” background_color=”#F2F2EB” custom_padding=”180px||130px||false|false” custom_padding_tablet=”180px||180px||true|false” custom_padding_phone=”100px||100px||true|false” global_colors_info=”{}”][et_pb_row module_class=”btn-inline” _builder_version=”4.21.0″ _module_preset=”default” custom_padding=”||55px||false|false” border_width_bottom=”1px” border_color_bottom=”#3B7C58″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#0A3D20″ text_font_size=”22px” text_font_size_tablet=”22px” text_font_size_phone=”19px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]Transition Corporate Finance Completes Transatlantic M&A Deal Acting as Sell-side Advisor to Netherlands-based Healthcare Company Clinical Trial Service in its Sale to US-based PCM Trials<\/strong> Amsterdam (12 January 2024)<\/strong> \u2013 PCM Trials, a US-based leader in providing mobile research nurses for decentralized clinical trials (DCTs), announced the acquisition of Netherlands-based Clinical Trial Service (CTS), with over 30 years\u2019 experience in managing and staffing global clinical trials with mobile research nurses for DCTs. The combined company further strengthens its global footprint with its ability to reach over 80 countries to support pharmaceutical sponsors and contract research organizations (CROs) in conducting the most complex international clinical trials. Transition Corporate Finance (TCF) acted as exclusive M&A advisor to the Seller in the sale to PCM Trials. Legal sell-side support was provided by international law firm AKD with international law firm Osborne Clarke acting as buy-side legal advisor.<\/p>\n \u201cCTS is a natural fit for us,\u201d<\/em> said Greg Austin, president of PCM Trials. \u201cTheir ability to understand an individual country\u2019s market, culture, and regulatory requirements allows us to launch and complete trials on schedule. This innovative model is designed to support sponsors and CROs looking to conduct global DCTs and deliver better patient retention and increased patient diversity.\u201d<\/em><\/p>\n The main driver for CRO M&A activity is the need for CROs to differentiate risk and change the scope of their business model to meet the demands of sponsors by accessing new therapeutic areas of expertise and technology improvements and obtain cost savings through enhanced scalability and geographical presence.<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”2_5″ module_class=”first-on-mobile” _builder_version=”4.22.2″ _module_preset=”default” custom_padding=”||25px||false|false” global_colors_info=”{}”][et_pb_image src=”https:\/\/transitioncf.com\/wp-content\/uploads\/2024\/01\/CTS.png” title_text=”PCM Trials acquires CTS” _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#0A3D20″ text_font_size=”22px” text_font_size_tablet=”22px” text_font_size_phone=”19px” text_font_size_last_edited=”on|phone” locked=”off” global_colors_info=”{}”]<\/p>\n TCF represented:<\/strong> Seller<\/p>\n Transaction type: <\/strong>M&A<\/p>\n Countries involved:\u00a0<\/strong>Netherlands, United States<\/p>\n Industry: <\/strong>Healthcare<\/p>\n Transitions: <\/strong>Decentralization, Digital transformation<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row module_id=”debt” module_class=”btn-inline” _builder_version=”4.22.2″ _module_preset=”default” custom_padding=”20px||55px||false|false” border_width_bottom=”1px” border_color_bottom=”#3B7C58″ global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text module_class=”linkhover” _builder_version=”4.22.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#0A3D20″ text_font_size=”22px” text_font_size_tablet=”22px” text_font_size_phone=”19px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n Willem op de Hoek, Partner at TCF adds: \u201cFor CROs to keep a competitive market position, a strategic premium in target valuation is justified. In addition, buy-and-build models enable mid-sized CROs to become interesting targets for private equity creating an exit opportunity for their shareholders.\u201d<\/em><\/p>\n Post transaction, Mirjam Bruggink (owner and founder of CTS) will remain with the company to ensure a smooth transition and will continue operations under the CTS brand serving its current and future customers. \u201cThis acquisition provided us with the ideal solution to grow our company and add financial strength to take us to the next level of service and innovation,\u201d<\/em>, said Mirjam Bruggink. \u201cAlso, big thank you to the entire TCF team. Sound professional support is absolutely essential in such complicated processes. TCF delivered an outstanding job.\u201d<\/em><\/p>\n For more information about Transition Corporate Finance or to explore any M&A related matter or other areas of strategic financial advisory, visit www.transitioncf.com<\/a> or email to info@transitioncf.com<\/a>.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.22.2″ _module_preset=”default” custom_padding=”55px||1px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_button button_url=”https:\/\/transitioncf.com\/en\/track-record\/” button_text=”Track record” button_alignment=”center” _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|desktop” _builder_version=”4.22.2″ _module_preset=”default” background_color=”#3B7C58″ custom_padding=”100px||100px||true|false” custom_padding_tablet=”100px||100px||true|false” custom_padding_phone=”80px||80px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” width=”60%” width_tablet=”80%” width_phone=”80%” width_last_edited=”on|phone” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#F2F2EB” header_2_text_align=”center” header_2_text_color=”#F2F2EB” text_orientation=”center” width_last_edited=”off|desktop” module_alignment=”center” header_2_font_size_tablet=”” header_2_font_size_phone=”24px” header_2_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.21.0″ _module_preset=”default” max_width=”1150px” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.21.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text module_class=”linkhover” _builder_version=”4.22.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#F2F2EB” link_text_color=”#F2F2EB” header_2_text_align=”center” header_2_text_color=”#F2F2EB” text_orientation=”center” max_width=”100%” module_alignment=”center” text_font_size_tablet=”” text_font_size_phone=”17px” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n Transition Corporate Finance B.V. | De Boelelaan 30, 1083 HJ Amsterdam | info@transitioncf.com<\/a> | LinkedIn<\/a> | CoC 89389492<\/p>\n <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n [\/et_pb_text][et_pb_button button_url=”https:\/\/transitioncf.com\/en\/contact\/” button_text=”Contact” button_alignment=”center” disabled_on=”off|off|off” _builder_version=”4.22.1″ _module_preset=”default” custom_button=”on” button_text_color=”#F2F2EB” button_border_color=”#F2F2EB” global_colors_info=”{}” button_border_color__hover_enabled=”on|hover” button_border_color__hover=”#F2F2EB”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Transition Corporate Finance next generation of M&A advisory . PCM TRIALS ACQUIRES CLINICAL TRIAL SERVICETransition Corporate Finance Completes Transatlantic M&A Deal Acting as Sell-side Advisor to Netherlands-based Healthcare Company Clinical Trial Service in its Sale to US-based PCM Trials Amsterdam (12 January 2024) \u2013 PCM Trials, a US-based leader in providing mobile research nurses for […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-1777","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/pages\/1777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/comments?post=1777"}],"version-history":[{"count":30,"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/pages\/1777\/revisions"}],"predecessor-version":[{"id":2035,"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/pages\/1777\/revisions\/2035"}],"wp:attachment":[{"href":"https:\/\/transitioncf.com\/en\/wp-json\/wp\/v2\/media?parent=1777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”3_5,2_5″ module_id=”mergers” module_class=”custom_row” _builder_version=”4.22.2″ _module_preset=”default” custom_padding=”55px||0px||false|false” border_style_all=”none” border_width_bottom=”1px” border_color_bottom=”#3B7C58″ global_colors_info=”{}”][et_pb_column type=”3_5″ module_class=”second-on-mobile” _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.22.2″ _module_preset=”default” text_font=”||||||||” text_text_color=”#0A3D20″ text_font_size=”22px” text_font_tablet=”||||||||” text_font_phone=”||||||||” text_font_last_edited=”on|desktop” text_font_size_tablet=”22px” text_font_size_phone=”19px” text_font_size_last_edited=”on|desktop” header_font_tablet=”” header_font_phone=”” header_font_last_edited=”on|desktop” global_colors_info=”{}”]<\/p>\nWe look forward to hearing your story<\/h2>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n